Skip to main content
. Author manuscript; available in PMC: 2018 Oct 15.
Published in final edited form as: Cancer. 2017 Jun 22;123(20):4066–4074. doi: 10.1002/cncr.30829

Table 1. CRC, PLP and CTRL characteristics of the study population in the discovery and validation phases.

Variables Discovery Phase Validation Phase


CRC, N (%) PLP, N (%) CTRL, N (%) P value CRC, N (%) PLP, N (%) CTRL, N (%) P value
Age( Mean, SD) 53.97(13.46) 51.87(10.82) 55.23(10.46) 0.67 58.66(10.28) 57.72( 9.21) 57.92( 9.91) 0.71
BMI( Mean, SD) 28.09( 5.20) 27.92( 5.77) 28.32( 6.18) 0.87 30.25( 5.61) 27.43( 5.58) 28.37( 8.67) 0.21
Sex
 Male 18(60.00) 18(60.00) 18(60.00) 23(46.00) 23(46.00) 23(46.00)
 Female 12(40.00) 12(40.00) 12(40.00) 1 27(54.00) 27(54.00) 27(54.00) 1
Smoking status
 Never 16(53.33) 20(66.67) 13(43.33) 31(62.00) 28(56.00) 30(60.00)
 Former 10(33.33) 8(26.67) 7(23.33) 15(30.00) 19(38.00) 15(30.00)
 Current 4(13.33) 2(6.67) 10(33.33) 0.07 4(8.00) 3(6.00) 5(10.00) 0.86
Smoker
 Ever 14(46.67) 10(33.33) 17(56.67) 19(38.00) 22(44.00) 20(40.00)
 Never 16(53.33) 20(66.67) 13(43.33) 0.19 31(62.00) 28(56.00) 30(60.00) 0.82
BMI
  <25 6(26.09) 9(32.14) 15(50.00) 7(15.91) 13(37.14) 25(50.00)
 ≥25 17(73.91) 19(67.86) 15(50.00) 0.16 37(84.09) 22(62.86) 25(50.00) <0.01

CRC, colorectal cancer; PLP, adenoma polyp; CTRL, control; SD, standard deviation; BMI, body mass index